Selective dose escalation of chemoradiotherapy for locally advanced esophageal cancer

Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
S K SeungHelen J Ross

Abstract

This phase II study assessed the use of concurrent continuous infusion of 5-fluorouracil and weekly carboplatin plus paclitaxel with selective radiation dose escalation for patients with localized esophageal cancer. Patients with esophageal carcinoma were staged by thoracic and abdominal computed tomography, endoscopic ultrasound, and positron emission tomography scans. Patients received a continuous infusion of 5-fluorouracil 225 mg/m(2) on days 1 to 38 and intravenous paclitaxel 45 mg/m(2) and carboplatin AUC 2 on days 1, 8, 15, 22, 29, and 36. Radiotherapy was delivered in 1.8-Gy fractions, 5 d/wk for 5.5 weeks. Six to 8 weeks after initial therapy, patients without metastatic progression but with a positive biopsy, or less than partial response received a 9-Gy boost with the same concurrent chemotherapy. Twenty-four patients were enrolled: 18 patients were enrolled initially; 6 additional patients were enrolled following a protocol amendment designed to reduce the esophagitis by adding the radioprotectant amifostine. Median follow-up was 30 months. Twenty (83%) patients had adenocarcinomas of the lower esophagus/gastroesophageal junction. Seventeen patients (81%) attained at least a partial response. Six patients received b...Continue Reading

References

Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A H CalvertE Wiltshaw
Jul 15, 1989·Cancer·P J HeskethS J Spechler
Jan 1, 1988·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·A RousselH Bleiberg
Apr 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E PoplinS E Rivkin
Feb 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L LeichmanJ Shell
Sep 15, 1993·JAMA : the Journal of the American Medical Association·W J BlotJ F Fraumeni
Jun 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A ForastiereM Zahurak
Aug 15, 1996·The New England Journal of Medicine·T N WalshT P Hennessy
Aug 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A E KorstW J van der Vijgh
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M I KoukourakisV Georgoulias
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S G UrbaM Strawderman
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D MinskyDavid P Kelsen

❮ Previous
Next ❯

Citations

Oct 27, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Jin-Bo MaChuan-Guo Hao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.